DutchNews, September 14, 2015
The pathology
professor at the centre of a conflict of interests case involving self-test
kits for cervical cancer is no longer part of the research team, the VU
University said on Monday.
Chris Meijer was involved in three companies which
stood to benefit from the switch to self-testing kits and had kept this secret,
the NRC reported in June.
The research project, involving 30,000 women, was
halted after the revelations and is now set to resume, the paper says on
Monday.
Meijer has also resigned from the government’s health council, where he
had also failed to come clean on his outside interests. The government agreed
to bring in self-testing for some women on the basis of the council’s advice.
The NRC revealed in June that Meijer has shares in and is joint owner of Delphi
Bioscience which makes the equipment women can use to take a sample for
testing. He is also part owner of Diassay which makes tests for the virus
thought to cause some forms of cervical cancer and which is also part of the
self-test system.
A third company in which Meijer has financial interests is
called Self-Screen and was competing for the tender to run the new programme,
the NRC says.

No comments:
Post a Comment
Note: Only a member of this blog may post a comment.